Companies: 10,795·Total market cap: $144.5T
Global Cord Blood Corporation

Global Cord Blood Corporation

CORBFOTCHealthcare● Active
$0.95
+$0.00(+0.00%)
Market Cap$127218975
P/E Ratio—
52W High$1.75
52W Low$0.2
Overview
Stock ranking:Medical - Diagnostics & Research·Healthcare·View All Market Cap Rankings →

Global Cord Blood Corporation (CORBF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CORBF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$3.89corbf eps ttm · corbf earnings per shareEarnings history
PE Ratio (TTM)0.2×corbf pe ratio ttm · corbf price to earningsPE Ratio deep dive
Revenue (TTM)$1.2Bcorbf revenue ttm · corbf annual revenueFull revenue history
Dividend Yield1.00%does corbf pay dividends · corbf dividend yieldDividend history
Shares Outstanding121.6Mcorbf shares outstanding · corbf floatShares outstanding history
Next EarningsTBAcorbf earnings date · corbf next earningsEarnings history

Explore Global Cord Blood Corporation Data

corbf stock data · financials
Market Cap$127.2Mcorbf market cap · corbf valuation
Analyst Forecast$— · Hold
Dividends1.00%does global cord blood corporation pay dividends · corbf dividend yield
Revenue$1.2B+7.21%global cord blood corporation annual revenue · corbf revenue
EarningsEPS $4.12-1.44%corbf earnings · corbf eps
PE Ratio0.2×corbf pe ratio · corbf price to earnings

Financial Snapshot

Full Financials
FY 2022Revenue$1.24B▲ +7.21% YoY
202020212022
global cord blood corporation revenue · corbf revenue 2022
FY 2022Net Income$501.1M▼ 1.41% YoY
202020212022
global cord blood corporation net income · corbf profit 2022
FY 2022EPS$4.12▼ 1.44% YoY
202020212022
corbf eps · global cord blood corporation earnings per share 2022
TTM:Revenue: $1.23BNet Income: $471.4MEPS: $3.89View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold3 analystsis corbf a buy · corbf analyst rating
Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$0.95Current
$—Avg Target
$—High
corbf price target · corbf 12 month forecast

Total: 3 · Buy rate: 33.3%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-20.17%
5Y-83.27%

About Global Cord Blood Corporation

CEOTing Zheng
IPO DateMay 9, 2007
Employees1,202
CountryHK
Websiteglobalcordbloodcorp.com

Global Cord Blood Corporation headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's…

Medical - Diagnostics & ResearchHealthcareOTCHK

what is global cord blood corporation · corbf stock overview · global cord blood corporation company profile · who is global cord blood corporation ceo · corbf OTC · global cord blood corporation headquarters · global cord blood corporation business segments

About Stock Overview & Key Data

Global Cord Blood Corporation (CORBF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since May 9, 2007. As of the latest trading session, CORBF stock price is $0.95, with a market capitalization of $127.2M. The stock has returned -20.17% over the past 12 months and +0.00% year-to-date.

According to 3 Wall Street analysts, the consensus rating for Global Cord Blood Corporation stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Global Cord Blood Corporation reported revenue of $1.2B and net income of $501.1M. For detailed data — including Global Cord Blood Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Global Cord Blood Corporation (CORBF) stock price is $0.95. The stock is traded on OTC under the ticker symbol CORBF. The 52-week range is $0.20 – $1.75.

CORBF stock priceCORBF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice